Lenvatinib and Nausea and vomiting - a phase IV clinical study of FDA data

Summary:

Nausea and vomiting is reported as a side effect among people who take Lenvatinib (lenvatinib), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Levothyroxine Sodium, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Nausea and vomiting when taking Lenvatinib. It is created by eHealthMe based on reports of 3,586 people who have side effects when taking Lenvatinib from the FDA, and is updated regularly.

What is Lenvatinib?

Lenvatinib has active ingredients of lenvatinib. eHealthMe is studying from 3,587 Lenvatinib users. Check the latest studies of Lenvatinib.

What is Nausea and vomiting?

Nausea and vomiting is found to be associated with 3,703 drugs and 5,745 conditions by eHealthMe. Check the latest studies of Nausea and vomiting.

On Jul, 22, 2026

3,586 people reported to have side effects when taking Lenvatinib.
Among them, 64 people (1.78%) have Nausea and vomiting.

Could Lenvatinib cause Nausea and vomiting?

Among these 64 people:

How long have people been on Lenvatinib when they have Nausea and vomiting? *

What is the gender of people who have Nausea and vomiting when taking Lenvatinib? *

female: 50.85 %
male: 49.15 %

What is the age of people who have Nausea and vomiting when taking Lenvatinib? *

What are other drugs people take besides Lenvatinib? *

What are other side effects people have besides Nausea and vomiting? *

Nausea (feeling of having an urge to vomit): 21 people, 32.81%
Diarrhea: 18 people, 28.12%
Fatigue (feeling of tiredness): 12 people, 18.75%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 9 people, 14.06%
High Blood Pressure: 8 people, 12.50%
Malignant Neoplasm Progression (cancer tumour came back): 6 people, 9.38%
Rashes (redness): 6 people, 9.38%
Pneumonia: 5 people, 7.81%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 7.81%
Palmar-Plantar Erythrodysaesthesia Syndrome (hand-foot syndrome): 5 people, 7.81%

What are the existing conditions these people have? *

Renal Cell Carcinoma (a kidney cancer): 19 people, 29.69%
Oesophageal Adenocarcinoma (a cancer tumour of an epithelium in oesophagus): 6 people, 9.38%
Hepatocellular Carcinoma (liver cancer): 6 people, 9.38%
High Blood Pressure: 4 people, 6.25%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 3 people, 4.69%
Endometrial Cancer: 3 people, 4.69%
Acute Kidney Failure: 3 people, 4.69%
Adenoid Cystic Carcinoma (cancer that can exist in many different body sites): 2 people, 3.12%
Ovarian Epithelial Cancer (cancer that begins in the cells on the surface of the ovary): 1 person, 1.56%
Renal Cell Carcinoma Recurrent (reoccurrence of kidney cancer): 1 person, 1.56%

* Approximation only. Some reports may have incomplete information.

Do you take Lenvatinib and have Nausea and vomiting?

- Check whether Nausea and vomiting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lenvatinib:

Lenvatinib (3,587 reports)

Browse all side effects of Lenvatinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea and vomiting:

Nausea and vomiting (3,703 drugs)

Browse all the conditions that are associated with Nausea and vomiting:

Nausea and vomiting (5,745 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenvatinib (the active ingredients of Lenvatinib) and Lenvatinib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.